Skip to main content

Research Repository

Advanced Search

Ninety‐Day Stroke Recurrence in Minor Stroke: Systematic Review and Meta‐Analysis of Trials and Observational Studies

Lim, Andy; Ma, Henry; Johnston, S. Claiborne; Singhal, Shaloo; Muthusamy, Subramanian; Wang, Yongjun; Pan, Yuesong; Coutts, Shelagh B.; Hill, Michael D.; Ois, Angel; Kapral, Moira K.; Knoflach, Michael; Woodhouse, Lisa J.; Bath, Philip M.; Phan, Thanh G.

Ninety‐Day Stroke Recurrence in Minor Stroke: Systematic Review and Meta‐Analysis of Trials and Observational Studies Thumbnail


Authors

Andy Lim

Henry Ma

S. Claiborne Johnston

Shaloo Singhal

Subramanian Muthusamy

Yongjun Wang

Yuesong Pan

Shelagh B. Coutts

Michael D. Hill

Angel Ois

Moira K. Kapral

Michael Knoflach

PHILIP BATH philip.bath@nottingham.ac.uk
Stroke Association Professor of Stroke Medicine

Thanh G. Phan



Abstract

Background Risk of recurrence after minor ischemic stroke is usually reported with transient ischemic attack. No previous meta‐analysis has focused on minor ischemic stroke alone. The objective was to evaluate the pooled proportion of 90‐day stroke recurrence for minor ischemic stroke, defined as a National Institutes of Health Stroke Scale severity score of ≤5. Methods and Results Published papers found on PubMed from 2000 to January 12, 2021, reference lists of relevant articles, and experts in the field were involved in identifying relevant studies. Randomized controlled trials and observational studies describing minor stroke cohort with reported 90‐day stroke recurrence were selected by 2 independent reviewers. Altogether 14 of 432 (3.2%) studies met inclusion criteria. Multilevel random‐effects meta‐analysis was performed. A total of 6 randomized controlled trials and 8 observational studies totaling 45 462 patients were included. The pooled 90‐day stroke recurrence was 8.6% (95% CI, 6.5–10.7), reducing by 0.60% (95% CI, 0.09–1.1; P =0.02) with each subsequent year of publication. Recurrence was lowest in dual antiplatelet trial arms (6.3%, 95% CI, 4.5–8.0) when compared with non‐dual antiplatelet trial arms (7.2%, 95% CI, 4.7–9.6) and observational studies 10.6% (95% CI, 7.0–14.2). Age, hypertension, diabetes, ischemic heart disease, or known atrial fibrillation had no significant association with outcome. Defining minor stroke with a lower National Institutes of Health Stroke Scale threshold made no difference – score ≤3: 8.6% (95% CI, 6.0–11.1), score ≤4: 8.4% (95% CI, 6.1–10.6), as did excluding studies with n<500%–7.3% (95% CI, 5.5–9.0). Conclusions The risk of recurrence after minor ischemic stroke is declining over time but remains important.

Citation

Lim, A., Ma, H., Johnston, S. C., Singhal, S., Muthusamy, S., Wang, Y., …Phan, T. G. (2024). Ninety‐Day Stroke Recurrence in Minor Stroke: Systematic Review and Meta‐Analysis of Trials and Observational Studies. Journal of the American Heart Association, 13(9), Article e032471. https://doi.org/10.1161/jaha.123.032471

Journal Article Type Article
Acceptance Date Mar 18, 2024
Online Publication Date Apr 19, 2024
Publication Date May 7, 2024
Deposit Date May 7, 2024
Publicly Available Date May 7, 2024
Journal Journal of the American Heart Association
Electronic ISSN 2047-9980
Publisher Wiley Open Access
Peer Reviewed Peer Reviewed
Volume 13
Issue 9
Article Number e032471
DOI https://doi.org/10.1161/jaha.123.032471
Public URL https://nottingham-repository.worktribe.com/output/34112155
Publisher URL https://www.ahajournals.org/doi/10.1161/JAHA.123.032471

Files




You might also like



Downloadable Citations